Rchr
J-GLOBAL ID:201401089160331894   Update date: Jan. 30, 2024

Kozaka Takashi

コザカ タカシ | Kozaka Takashi
Affiliation and department:
Job title: Assistant Professor
Homepage URL  (1): http://ri-center.w3.kanazawa-u.ac.jp/
Research field  (1): Radiology
Research keywords  (1): Organic synthetic chemistry, Radiopharmaceutical chemistry, Molecular imaging
Research theme for competitive and other funds  (7):
  • 2020 - 2023 σ受容体を標的とした新規固形がんイメージング剤と抗がん剤の開発
  • 2019 - 2022 Development of sigma-1 receptor imaging agent for early diagnosis of stress-related diseases
  • 2017 - 2020 Development of a new sigma-2 receptor ligand for imaging and BNCT
  • 2014 - 2017 アルツハイマー病の早期診断用シナプス前コリン作動性神経分子イメージング剤の開発
  • 2014 - 2016 固形腫瘍の早期発見・増殖能診断を目的としたσ-2受容体イメージング剤の開発研究
Show all
Papers (35):
  • Hiroshi Wakabayashi, Hiroshi Mori, Tomo Hiromasa, Norihito Akatani, Anri Inaki, Takashi Kozaka, Yoji Kitamura, Kazuma Ogawa, Seigo Kinuya, Junichi Taki. 125I-labeled 2-[4-(2-iodophenyl)piperidino]cyclopentanol (125I-OI5V) imaging visualized augmented sigma-1 receptor expression according to the severity of myocardial ischemia. Journal of Nuclear Cardiology. 2022
  • Hiroshi Wakabayashi, Junichi Taki, Hiroshi Mori, Tomo Hiromasa, Norihito Akatani, Anri Inaki, Takashi Kozaka, Kazuhiro Shiba, Kazuma Ogawa, Seigo Kinuya. Visualization of Dynamic Expression of Myocardial Sigma-1 Receptor After Myocardial Ischemia and Reperfusion Using Radioiodine-Labeled 2-[4-(2-iodophenyl)piperidino]cyclopentanol (OI5V) Imaging. Circulation journal : official journal of the Japanese Circulation Society. 2021. 85. 11. 2102-2108
  • Taiki Shigeno, Takashi Kozaka, Yoji Kitamura, Kazuma Ogawa, Junichi Taki, Seigo Kinuya, Kazuhiro Shiba. In vitro and in vivo evaluation of [125/123I]-2-[4-(2-iodophenyl)piperidino]cyclopentanol([125/123I]-OI5V) as a potential sigma-1 receptor ligand for SPECT. Annals of nuclear medicine. 2021. 35. 2. 167-175
  • Daisuke Miwa, Yoji Kitamura, Takashi Kozaka, Taiki Shigeno, Kazuma Ogawa, Junichi Taki, Seigo Kinuya, Kazuhiro Shiba. (-)-o-[11 C]methyl-trans-decalinvesamicol ((-)-[11 C]OMDV) as a PET ligand for the vesicular acetylcholine transporter. Synapse (New York, N.Y.). 2020. 74. 11. e22176
  • Tuyen Thuy Bich Ho, Alessandro Nasti, Akihiro Seki, Takuya Komura, Hiiro Inui, Takashi Kozaka, Yoji Kitamura, Kazuhiro Shiba, Taro Yamashita, Tatsuya Yamashita, et al. Combination of gemcitabine and anti-PD-1 antibody enhances the anticancer effect of M1 macrophages and the Th1 response in a murine model of pancreatic cancer liver metastasis. Journal for immunotherapy of cancer. 2020. 8. 2
more...
MISC (1):
  • K. Ogawa, H. Kanbara, K. Shiba, Y. Kiyono, T. Mori, Y. Kitamura, T. Kozaka, T. Kiwada, A. Odani. Development and evaluation of a radiobromine labeled sigma ligand for tumor imaging. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING. 2011. 38. S147-S147
Lectures and oral presentations  (58):
  • Study on the Application of ATR for the Measurement of Infrared Absorption Spectrum of Food Adductives Identification Tests
    (137th Annual Meeting of the Pharmaceutical Society of Japan 2017)
  • The structure-activity relationship between structure of vesamicol analogs and affinity of VAChT and sigma receptors.
    (137th Annual Meeting of the Pharmaceutical Society of Japan 2017)
  • The possibility of vesamicol analog with 5-membered ring as a sigma-1 receptor imaging probe
    (137th Annual Meeting of the Pharmaceutical Society of Japan 2017)
  • Changes of the dopamine nerve system by stress in the model mouse for 15q duplication.
    (137th Annual Meeting of the Pharmaceutical Society of Japan 2017)
  • SPECT用σ-2受容体イメージング剤[<sup>123</sup>I]PIDVの開発研究
    (第56回日本核医学会学術総会 2016)
more...
Professional career (1):
  • 博士(薬学)
Association Membership(s) (6):
Society of Nuclear Medicine and Molecular Imaging ,  Japanese Society of Radiation Safety Management ,  Japan Radioisotope Association ,  Japanese Society for Molecular Imaging ,  The Pharmaceutical Society of Japan ,  The Japanese Society of Nuclear Medicine
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page